(Q44228340)

1 December 2017

title

Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). (English)

1 reference

1 December 2017

main subject

acute coronary syndrome

1 reference

6

Eugene Braunwald

1 reference

1 December 2017

1

James L Januzzi

1 reference

1 December 2017

2

Christopher P Cannon

1 reference

1 December 2017

4

Sabina Murphy

1 reference

1 December 2017

3

Peter M DiBattiste

1 reference

1 December 2017

William Weintraub

5

1 reference

1 December 2017

TACTICS-TIMI 18 Investigators

series ordinal

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

American Journal of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

90

1 reference

1 December 2017

issue

11

1 reference

1 December 2017

page(s)

1246-1249

1 reference

Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. The ECLA Collaborative Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Renal disease as a risk factor for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Current status of prevention, diagnosis, and management of coronary artery disease in patients with kidney failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902844-8

10.1016/S0002-9149(02)02844-8

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference